Skip to main content
Anixa Biosciences Inc logo

Anixa Biosciences Inc — Investor Relations & Filings

Ticker · ANIX ISIN · US45069V2034 LEI · 549300PW2C2QTAJL2D19 US Professional, scientific and technical activities
Open in API
Filings indexed 958 across all filing types
Latest filing 2011-11-30 Interim / Quarterly Rep…
Country US United States of America
Listing US ANIX

About Anixa Biosciences Inc

https://www.anixa.com/

Anixa Biosciences Inc. is a clinical-stage biotechnology company focused on developing therapies and vaccines for the treatment and prevention of cancer. The company's portfolio is centered on two main platforms: a therapeutics program and a vaccine program. The therapeutics portfolio features a Chimeric Antigen Receptor T-cell (CAR-T) immunotherapy, which genetically engineers a patient's own immune cells to target and destroy solid tumors. The vaccine portfolio includes preventative and therapeutic candidates for various cancers, with a primary focus on breast and ovarian cancer, and discovery programs for lung, colon, and prostate cancer. Anixa aims to address critical unmet needs in oncology through these innovative approaches.

Recent filings

Filing Released Lang Actions
AMENDMENT NO. 2 TO FORM 10-Q
Interim / Quarterly Report Q3 2011
2011-11-30 English
FORM 8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated October 26, 2011, reporting on the Annual Meeting of Stockholders of CopyTele, Inc. It details the submission of matters to a vote of security holders, including election of directors and ratification of the appointment of auditors. The content focuses on voting results from the Annual Meeting, not the meeting materials themselves or a full annual report. The document length is 3306 characters, which is relatively short and consistent with a voting results announcement. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2011-11-03 English
MAIN DOCUMENT DESCRIPTION
Director's Dealing
2011-10-31 English
FORM 10-Q AMENDMENT NO. 1
Interim / Quarterly Report Q3 2011
2011-10-14 English
DEFINITIVE PROXY STATEMENT
Proxy Solicitation & Information Statement
2011-09-22 English
FORM 10-Q
Interim / Quarterly Report 9M 2011
2011-09-14 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.